Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Neoplasms 52Neoplasm Metastasis 41Multiple Myeloma 40Lymphoma 40Lung Neoplasms 38Breast Neoplasms 37Prostatic Neoplasms 31Carcinoma, Non-Small-Cell Lung 31Leukemia, Myeloid, Acute 30Melanoma 27Colorectal Neoplasms 27Ovarian Neoplasms 26Urinary Bladder Neoplasms 22Pancreatic Neoplasms 22Hematologic Neoplasms 22Lymphoma, Non-Hodgkin 21Glioma 21Carcinoma, Renal Cell 20Sarcoma 18Myelodysplastic Syndromes 16Burkitt Lymphoma 16Triple Negative Breast Neoplasms 15Stomach Neoplasms 15Neuroblastoma 14Colonic Neoplasms 14Brain Neoplasms 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, Large B-Cell, Diffuse 13Leukemia, Lymphocytic, Chronic, B-Cell 13Fallopian Tube Neoplasms 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Lymphohistiocytosis, Hemophagocytic × 30 days × Clear all
NCT03827343 2026-06-05

Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer

National Institutes of Health Clinical Center (CC)

Active not recruiting
500 enrolled
Myeloid

Lymphohistiocytosis, Hemophagocytic, Macrophage Activation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡